Skip to content
Screener

Aspen Aerogels ASPN Q4 2025 Annual earnings

Reported February 25, 2026 · Before market open

Revenue$41.3MMiss by $2.9M
EPS-$0.34Miss by $0.07
Revenue estimate$44.3M
EPS estimate-$0.27

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$71.1M
EPS estimate-$0.09

Financials

Q4 2025

Income statement

See full
Revenue$41.3M-66.4%
Operating income-$70.4M-578%
Net income-$72.9M-742%
EPS (diluted)-$0.88-729%

Balance sheet

See full
Cash & equivalents$156.9M-29.0%
Total debt$120.0M-15.0%
Total equity$235.5M-61.7%
Total assets$406.7M-54.6%

Cash flow

See full
Operating cash flow$16.1M-54.8%
CapEx$2.5M-83.3%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$233.89M-76.0%
Enterprise value$197M-78.0%
P/S0.9×-1.3×

Profitability

See full
Operating margin-139.5%-152pp
Net margin-143.7%-147pp

Returns & leverage

See full
Return on equity-91.6%-94.1pp
Debt / equity0.5×+0.3×
Current ratio3.9×+0.2×

Segments

By geography

See full
Asia$9.0M-19.9%
Europe$4.1M-77.1%
Latin America$764.0K-97.1%

By product

See full
Energy Industrial$25.3M-52.4%

FAQ

When did Aspen Aerogels report Q4 2025 earnings?
Aspen Aerogels (ASPN) reported Q4 2025 earnings on February 25, 2026 before market open.
What were Aspen Aerogels's Q4 2025 revenue and EPS?
Aspen Aerogels reported revenue of $41.3M and eps of $-0.34 for Q4 2025.
Did Aspen Aerogels beat estimates in Q4 2025?
Revenue missed the consensus estimate of $44.3M by $2.9M. EPS missed the consensus estimate of $-0.27 by $0.07.
How did Aspen Aerogels's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 66.4% from $123.1M a year earlier.
Where can I find Aspen Aerogels's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001171843-26-001072) and the 10-K periodic report (0001193125-26-106453) directly on SEC EDGAR. The filing index links above go to sec.gov.